Provinces want lower price for U.S. drug

By: The Canadian Press

 | Apr 03, 2014 - 3:01 PM |
TORONTO - Provincial governments are banding together to pressure a pharmaceutical manufacturer to finalize a price for a drug that treats a rare form of cystic fibrosis.

The provinces are asking U.S.-based Vertex Pharmaceuticals, which makes Kalydeco, to come to Canada and explain why Canadians have to pay a premium for the lifesaving drug, which costs patients hundreds of thousands of dollars a year.

Alberta Health Minister Fred Horne says it's unfair that Canadians have to pay more for the drug compared to Americans.

He says there is a small group of children who have been able to get the drug through clinical trials and Vertex has covered that.

But he says families haven't been able to access the drug on compassionate grounds as is often the case with other drugs.

There are about 118 Canadians who would be eligible for the drug, including 21 in Alberta.

Reader's Feedback

NorthernLife.ca may contain content submitted by readers, usually in the form of article comments. All reader comments and any opinions, advice, statements or other information contained in any messages posted or transmitted by any third party are the responsibility of the author of that message and not of NorthernLife.ca. The fact that a particular message is posted on or transmitted using this web site does not mean that NorthernLife.ca has endorsed that message in any way or verified the accuracy, completeness or usefulness of any message. We encourage visitors to NorthernLife.ca to report any objectionable content by using the "report abuse" link found in the comments section of this web site. Comment Guidelines

comments powered by Disqus

Most Popular

Local Business Directory